← Top stories
Broker call▲ Bullish for Artemis Medicare Services
Artemis Medicare surges 14% on huge volume; zooms 87% from April low
The brief
- Artemis Medicare shares surged 14% and rose 87% from their April low
- InCred initiated coverage with a Buy rating and ₹437 target
- The Buy call and earnings-growth outlook matter to investors in hospital stocks, including Artemis Medicare
| Stock | Traded | That day | vs Nifty | Volume | Since |
|---|---|---|---|---|---|
| ARTEMISMED | Fri, 25 Sept | +7.5% | +7.2% | 50× | +7.5% · Nifty +0.3% |
✓ Classifier read this as positive; ARTEMISMED rose 7.2% against the Nifty on the day it traded.
- Rs 4 lakh crore loss! Why India's storied consumer stocks are languishing near the bottom in 2026
- Clean Max shares see a ₹1,199 crore block deal amid volatile trading
- PB Fintech: the risk was known. Investors chased the stock anyway
- At 43 times earnings, NSE valued way higher than its global peers
- Rising US bond yields weigh on Indian stocks, add pressure on valuations